Category: Point-of-Care
Point-of-Care market research reports by Frost & Sullivan
-
Global Clinical Diagnostics Outlook, 2024
Global Clinical Diagnostics Outlook, 2024 Driven by Digital Services and Automation, the Molecular Diagnostics and POCT Sectors Rebound after the COVID-19 Pandemic With the end of the COVID-19 pandemic, healthcare providers have been directing most of their capabilities toward preventive healthcare ... Read More
-
Direct-to-Consumer Wellness Testing Growth Opportunities
Direct-to-Consumer Wellness Testing Growth Opportunities The COVID-19 pandemic accelerated the shift toward greater adoption of decentralized healthcare, building trust by demonstrating the feasibility and ease of testing at home and in pharmacies with accurate results, including self-sampling optio ... Read More
-
Global Point-of-care Testing Growth Opportunities
Global Point-of-care Testing Growth Opportunities This study provides an overview of the global point-of-care testing (POCT) industry, which refers to any routine or specialized lab pathology testing conducted rapidly, on-site/near the site of the patient, where care or treatment is provided. COVID- ... Read More
-
Frost Radar™: Point-of-Care Ultrasound (Portable and Ultraportable), 2023
Frost Radar™: Point-of-Care Ultrasound (Portable and Ultraportable), 2023 A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines Portable and ultraportable point-of-care ultrasound (POCUS) systems have gained prominence in recent years due to th ... Read More
-
Asia-Pacific Next-generation Diagnostics Outlook, 2023
Asia-Pacific Next-generation Diagnostics Outlook, 2023 The Renewed Focus on Infectious Diseases Outside COVID-9, Oncology, Cardiovascular, Diabetes, and Prenatal Care will Drive Market Growth The Asia-Pacific next-generation diagnostics market's revenue is projected to decline by 5.0% in 2023, attri ... Read More
-
Cardiac Troponin Diagnostics-Forecasts and Opportunities to 2025
Cardiac Troponin Diagnostics-Forecasts and Opportunities to 2025 Cardiac troponin (cTn) biomarkers are the gold standard in myocardial infarction (MI) diagnosis, leading healthcare professionals to use cTn diagnostics. In addition, a rising number of patients visit emergency departments (EDs) with c ... Read More
-
United States Molecular Point-of-Care Testing Growth Opportunities
United States Molecular Point-of-Care Testing Growth Opportunities Rapid advancements in infectious disease diagnostics continue with novel identification methods and healthcare accessibility improvements. The shift from traditional testing to a more technologically empowered, consumer-centric testi ... Read More
-
Next-generation Diagnostics Outlook, 2022
Next-generation Diagnostics Outlook, 2022 In vitro diagnostics introduces new technologies, sequencing methods, novel software algorithms, and multi-omics approaches to realise the goal of personalized medicine. Next-generation diagnostics has been the backbone of COVID-19-related emergency diagnosi ... Read More
Research Assistance
